REDX — Redx Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- £35.01m
- £34.60m
- £4.20m
Annual cashflow statement for Redx Pharma, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.21 | -21.6 | -18 | -33.2 | -17.5 |
| Depreciation | |||||
| Non-Cash Items | 1.5 | 5.62 | 6.09 | 2.53 | 2.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7.44 | -6.05 | 2.56 | -5.08 | -2.95 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.395 | -21.4 | -8.47 | -34.7 | -17.2 |
| Capital Expenditures | -0.059 | -0.754 | -0.262 | -0.195 | -0.037 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.004 | 0 | 0.021 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.055 | -0.754 | -0.241 | -0.195 | -0.037 |
| Financing Cash Flow Items | -1.52 | -1.05 | -0.77 | 0 | -0.492 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.5 | 24.1 | 33 | -0.816 | 17.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.8 | 2.04 | 24.3 | -35.8 | 0.465 |